What factor influences the choice between nine months of INH and the 3HP regimen in latent TB for HIV patients?

• A. ART interactions
• B. Age
• C. Geographical location
• D. Weight

Answer: (A)

Drug interactions between rifamycins and antiretroviral therapy determine which latent TB regimen is suitable for people living with HIV. Rifapentine, used in the 3HP regimen, strongly induces liver enzymes that metabolize many antiretrovirals. This can lower antiretroviral drug levels, risking inadequate HIV control or resistance, unless ART is adjusted to a compatible regimen. If a patient’s ART cannot be safely combined with rifapentine, the 9 months of isoniazid (INH) becomes the preferred option. When possible, clinicians may modify ART to allow a rifamycin-containing course, but the potential for interactions is the central consideration. Age, weight, or geographical location do not drive this interaction risk in the same way.